by Allison Sit Healio covered three studies from the June issue of the Journal of Drugs in Dermatology, including one about dapsone gel for acne patients with skin of color.…
Read More
by Allison Sit Three studies from the May issue of the Journal of Drugs in Dermatology are already making news. Healio wrote about a skincare regimen that can address adverse…
Read More
by Allison Sit Dermatology Times, HAPPI, Healio and HealthDay all wrote about an April article in the Journal of Drugs in Dermatology that was one of one of the largest,…
Read More
by Allison Sit Dermatology Advisor, Dermatology Times and Healio all covered recent articles in the Journal of Drugs in Dermatology. One study, “Cysteamine Isobionic-Amide Complex Versus Kligman’s Formula for the…
Read More
by Allison Sit Dermatology Advisor, Dermatology News, Healio, Medriva and Medscape all covered a Journal of Drugs in Dermatology study about the long-term safety and effectiveness of topical clascoterone for…
Read More
by Allison Sit The Journal of Drugs in Dermatology made news in Healio recently with several articles including one about a combination therapy for non-melanoma skin cancer. The study, “Cryosurgery…
Read More
by Allison Sit Healio wrote about a recent Journal of Drugs in Dermatology study on telehealth usage from a physician’s perspective. The study, “Telemedicine Versus Teledermatology Usage and Perception Among…
Read More
2023 JDD Welcome Kit The Journal of Drugs in Dermatology (JDD) and its sponsors are welcoming the latest dermatology residency graduates into the specialty. Graduates from 2023 are each receiving…
Read More
by Allison Sit A Journal of Drugs in Dermatology study on the availability of oral minoxidil made news in several media outlets, including NBC News, HealthDay, Practical Dermatology and Dermatology…
Read More
Healio featured several September JDD studies in its recent dermatology news coverage including a study on using fractional lasers for skin cancer prevention. The study, “Fractional Laser for Prevention of…
Read More
Dermatology Times featured a JDD study on whether race plays a factor in access to biologics. The study, “No Racial Differences Found in Access to Biologics: A Population-Based Study of…
Read More
Healio featured a JDD study on the use of tildrakizumab for plaque psoriasis. Jayme Heim, MSN, FNP-BC, and colleagues wrote, “Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe…
Read More
